Inventor · disambiguated record
Gerd Sutter
Also filed as: SUTTER GERD
11 granted patents·11 pending applications·230 citations·filing 1997–2023
91Inventor score
Top patents by PatentIndex Score
22 records- 0193US6440422B1Recombinant MVA virus, and the use thereofGSF FORSCHUNGSZENTRUM UMWELT·Filed 1998·Granted Aug 27, 2002·104 cites·33 claims
- 0292US8197825B2Recombinant MVA virus and the use thereofSUTTER GERD·Filed 2010·Granted Jun 12, 2012·24 cites·18 claims
- 0388US6682742B1Vector for integration of heterologous sequences into poxviral genomesGSF FORSCHUNGSZENTRUM FUR UNWE·Filed 2000·Granted Jan 27, 2004·32 cites·19 claims
- 0485US7049145B2Vaccinia virus MVA-E3L-knockout-mutants and use thereofGSF FORSCHUNGSZENTRUM UMWELT·Filed 2002·Granted May 23, 2006·23 cites·23 claims
- 0582US7767209B2Modified vaccinia virus Ankara (MVA) mutant and use thereofGSF FORSCHUNGSZENTRUM UMWELT·Filed 2006·Granted Aug 3, 2010·11 cites·15 claims
- 0681US7198934B2Recombinant MVA virus, and the use thereofGSF FORSCHUNGSZENTRUM UMWELT·Filed 2002·Granted Apr 3, 2007·12 cites·34 claims
- 0779US8153138B2Recombinant MVA virusSUTTER GERD·Filed 2006·Granted Apr 10, 2012·2 cites·10 claims
- 0874US11633441B2Immuno-modulated replication-efficient vaccinia virus strainSUTTER GERD·Filed 2018·Granted Apr 25, 2023·1 cites·14 claims
- 0973US12295979B2Immuno-modulated replication-efficient Vaccinia virus strainSUTTER GERD·Filed 2023·Granted May 13, 2025·0 cites·13 claims
- 1061US7150874B2Vector for integration of heterologous sequences into poxviral genomesGFS FORSCHUNGSZENTRUM FUR UMWE·Filed 2003·Granted Dec 19, 2006·1 cites·36 claims
- 1159US2009238843A1Recombinant mva capable of expressing structural hcv antigensSUTTER GERD·Filed 2009·Application pending·0 cites
- 1258US6869793B2Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccinesBAVARIAN NORDIC AS·Filed 1997·Granted Mar 22, 2005·20 cites·5 claims
- 1353US2004265324A1Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccinesFiled 2004·Application pending·0 cites
- 1450US2005287162A1Recombinant fowlpox virusBAIER ROBERT·Filed 2003·Application pending·0 cites
- 1550US2013089569A1Recombinant mva capable of expressing structural hcv antigensHELMHOLTZ ZENTRUM MUENCHEN·Filed 2012·Application pending·0 cites
- 1648US2011293656A1Recombinant mva capable of expressing structural hcv antigensSUTTER GERD·Filed 2011·Application pending·0 cites
- 1746US2006127413A1Recombinant mva strains as potential vaccines against p. falciparum malariaSUTTER GERD·Filed 2003·Application pending·0 cites
- 1845US2005019347A1Recombinant mva capable of expressing structural hcv antigensFiled 2002·Application pending·0 cites
- 1944US2006002896A1Method of generating recombinant MVASTAIB CAROLINE·Filed 2005·Application pending·0 cites
- 2041US2008075694A1MVA vaccineDREXLER INGO·Filed 2007·Application pending·0 cites
- 2139US2009191157A1Use of recombinant modified vaccinia virus ankara (mva) for the treatment of type 1 hypersensitivity in a living animal including humansPAUL ENRLICH INST BUNDESAMT FU·Filed 2007·Application pending·0 cites
- 2239US2011020391A1Recombinant modified vaccinia virus ankara (mva)-based vaccine for the avian fluPAUL EHRLICH INST BUNDESAMT FUR SERA UND IMPFSTOFFE·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Gerd Sutter files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →